Authors:
Meissner, M
Brecht, S
Bujard, H
Soldati, D
Citation: M. Meissner et al., Modulation of myosin A expression by a newly established tetracycline repressor-based inducible system in Toxoplasma gondii, NUCL ACID R, 29(22), 2001, pp. NIL_58-NIL_67
Authors:
Lutz, R
Lozinski, T
Ellinger, T
Bujard, H
Citation: R. Lutz et al., Dissecting the functional program of Escherichia coli promoters: the combined mode of action of Lac repressor and AraC activator, NUCL ACID R, 29(18), 2001, pp. 3873-3881
Authors:
Hess, J
Nielsen, PJ
Fischer, KD
Bujard, H
Wirth, T
Citation: J. Hess et al., The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development, MOL CELL B, 21(5), 2001, pp. 1531-1539
Authors:
Verhoef, K
Marzio, G
Hillen, W
Bujard, H
Berkhout, B
Citation: K. Verhoef et al., Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat, J VIROLOGY, 75(2), 2001, pp. 979-987
Authors:
Lavon, I
Goldberg, I
Amit, S
Landsman, L
Jung, S
Tsuberi, BZ
Barshack, I
Kopolovic, J
Galun, E
Bujard, H
Ben-Neriah, Y
Citation: I. Lavon et al., High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappa B activation, NAT MED, 6(5), 2000, pp. 573-577
Citation: U. Baron et H. Bujard, Tet repressor-based system for regulated gene expression in eukaryotic cells: Principles and advances, METH ENZYM, 327, 2000, pp. 401-421
Authors:
Jahn, R
Bock, A
Breiner, KM
Breunig, KD
Bujard, H
Campos-Ortega, J
Ganten, D
Grummt, I
Gruss, P
Goridis, C
Huber, R
Hoch, M
Jackle, H
Kahmann, R
Koch-Brandt, C
Leptin, M
Michel, H
Noegel, A
Neher, E
Nusslein-Volhard, C
Pfanner, N
Sandhoff, K
Schoen, A
Schwille, P
Simons, K
Zrenner, E
Citation: R. Jahn et al., Distinguished scientists back Germany's DFG . . ., NATURE, 404(6781), 2000, pp. 922-922
Authors:
Urlinger, S
Baron, U
Thellmann, M
Hasan, MT
Bujard, H
Hillen, W
Citation: S. Urlinger et al., Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity, P NAS US, 97(14), 2000, pp. 7963-7968
Authors:
Freundlieb, S
Schirra-Muller, C
Bujard, H
Citation: S. Freundlieb et al., A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells, J GENE MED, 1(1), 1999, pp. 4-12
Authors:
Redfern, CH
Coward, P
Degtyarev, MY
Lee, EK
Kwa, AT
Hennighausen, L
Bujard, H
Fishman, GI
Conklin, BR
Citation: Ch. Redfern et al., Conditional expression and signaling of a specifically designed G(i)-coupled receptor in transgenic mice, NAT BIOTECH, 17(2), 1999, pp. 165-169
Authors:
Pan, WQ
Ravot, E
Tolle, R
Frank, R
Mosbach, R
Turbachova, I
Bujard, H
Citation: Wq. Pan et al., Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells, NUCL ACID R, 27(4), 1999, pp. 1094-1103
Authors:
Burghaus, PA
Gerold, P
Pan, WQ
Schwarz, RT
Lingelbach, K
Bujard, H
Citation: Pa. Burghaus et al., Analysis of recombinant merozoite surface protein-1 of Plasmodium falciparum expressed in mammalian cells, MOL BIOCH P, 104(2), 1999, pp. 171-183
Authors:
Baron, U
Schnappinger, D
Helbl, V
Gossen, M
Hillen, W
Bujard, H
Citation: U. Baron et al., Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes, P NAS US, 96(3), 1999, pp. 1013-1018